Lifecore Biomedical, Inc. (LFCR) company profile

Lifecore Biomedical, Inc. is a contract development and manufacturing organization that specializes in the development, manufacturing, and aseptic filling of sterile injectable pharmaceutical drugs and medical devices. The company manufactures pharmaceutical-grade hyaluronic acid through bacterial fermentation in both bulk and filled formats such as syringes, vials, and cartridges, alongside non-hyaluronic acid formulations. Its service offerings include formulation development, analytical method validation, process scale-up, stability testing, and clinical trial material production. Lifecore manages its operations through a single integrated business segment. The company serves emerging and global biopharmaceutical and biotechnology firms, as well as academic and commercial research organizations.

The company is headquartered in Chaska, Minnesota, where it operates three manufacturing facilities encompassing a total of 250,000 square feet within a two-mile radius. Lifecore employs 406 full-time workers, all based in the United States. Its production sites maintain regulatory clearances and certifications from authorities in the United States, Europe, Japan, and Brazil.

Summary of the business section of Lifecore Biomedical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, the Company had 382 full-time employees, of whom 177 were dedicated to manufacturing, 93 to quality and regulatory affairs, 78 to general operations, and 34 to sales, marketing and administrative activities.”